Physician Transaction Advisors
Physician Transaction Advisors is the current name of ASCs Inc. The firm describes an advisory model for physician-owners that includes strategy development, buyer outreach, competitive bids, diligence, negotiation, and closing support.
What stands out about Physician Transaction Advisors
Physician Transaction Advisors publicly positions itself as a seller-side advisor to physician-owners evaluating strategic partnerships involving practices, ambulatory surgery centers, specialty facilities, and related real estate. Its stated process includes confidential buyer outreach, competitive bids, quality-of-earnings work, diligence, offer review, negotiation, and closing support.[1][2][3][6]
What does Physician Transaction Advisors do?
Physician Transaction Advisors is the current name of ASCs Inc., which changed its name as its work expanded beyond surgery centers to group practices and related transactions.
The firm describes itself as an advisor representing physician-owners rather than an investment banking or brokerage company. Its stated focus is evaluating strategic partnership options involving practices, surgery centers, specialty facilities, and related real estate.[1][3]
PTA’s stated process includes strategy development, due diligence, preparation of a confidential information memorandum and secure data room, confidential marketing to qualified buyers, competitive bids, offer review, negotiation, quality-of-earnings work, and closing support.[2]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Physician Transaction Advisors?
Owners evaluating PTA should clarify which legal entity would sign the engagement letter and which services are included under the stated risk- and cost-free-until-closing model. The engagement should also be reviewed for fee, success-fee, tail, expense-reimbursement, and termination provisions.
Because PTA describes outreach to hospitals, healthcare systems, private-equity-backed platforms, management companies, consolidators, and other potential partners, an owner may want to establish which buyer groups would be contacted for the specific practice or surgery center and how conflicts would be handled. Owners should also address how valuation, rollover equity, governance, clinical autonomy, earn-outs, real-estate interests, and other transaction terms would be evaluated.[2][3][5]
What fee, success-fee, tail, expense-reimbursement, and termination provisions apply
Which buyer groups would be contacted for a specific practice or surgery center, and how are conflicts handled
What size transactions and clients does Physician Transaction Advisors focus on?
PTA publicly identifies ambulatory surgery centers, orthopedic practices, gastroenterology and endoscopy practices, pain and spine practices, urology practices, and ophthalmology practices as markets served.[4]
PTA’s official pages identify Digestive Disease Physicians entering a strategic partnership with GastroHealth; South Bend Orthopaedics entering a partnership with OrthoAlliance; and Spectrum Orthopaedics entering a strategic partnership with Growth Orthopedics and rebranding as Orthopaedic Associates of Maine.
Other identified examples include Surgery Center of Gilbert entering a strategic partnership with Atlas Healthcare Partners and Banner Health; Advanced Pain and Spine Centers and Executive Surgery Center of Little Rock entering a strategic partnership with DxTx Pain and Spine; Choice Care Surgery Center entering a joint venture involving a regional hospital and a national surgical-services provider; and Florida Urology Center entering a partnership with U.S. Urology Partners.[7][8][9][10][11][12]
The firm’s public positioning centers on physician-owner strategic partnerships and related healthcare transactions. Its stated buyer network includes private-equity-backed platforms, hospitals and healthcare systems, surgery-center management companies, groups seeking to merge or expand, and other potential partners.[3]
What does Physician Transaction Advisors publicly disclose about fees, process and engagement terms?
The cited Clients page names featured transactions but does not publish transaction values, consideration terms, ownership percentages, or detailed closing dates for the listed examples.
The same Clients page identifies client categories and sectors but does not publish a universal revenue, EBITDA, enterprise-value, physician-count, or minimum-transaction-size threshold.[6]
PTA states that it is not an investment banking or brokerage company and describes its model as advisory representation of physician-owners.
The cited About page does not state a specific legal-entity form or firm-level broker-dealer or investment-adviser registration number.[3]
PTA describes a process that includes confidential marketing to qualified buyers, competitive bids, offer review, negotiation, diligence, quality-of-earnings work, and closing support. It states that the process is risk- and cost-free and that clients are not obligated to consummate a transaction if the prospective partner does not meet their goals.[2]
Questions to ask before hiring Physician Transaction Advisors
Which legal entity signs the engagement letter, and what services are included under the stated risk- and cost-free-until-closing model?
What fee, success-fee, tail, expense-reimbursement, and termination provisions apply?
Which buyer groups would be contacted for a specific practice or surgery center, and how are conflicts handled?
How are valuation, rollover equity, governance, employment, clinical autonomy, earn-outs, real-estate interests, and other transaction terms evaluated?
Can PTA provide transaction-specific references and explain the dates, scope, and consideration terms of comparable engagements?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Services / capabilities
- Industry / market focus
- Geography / market coverage
- Public disclosure information
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.